The most recent surveillance data from UK Health Security Agency (UKHSA)
indicates that circulation of influenza in the community has returned to baseline
levels.
In accordance with NICE guidance and Schedule 2 to the National Health Service
(General Medical Services Contracts) (Prescription of drugs etc.) Regulations 2004),
commonly known as the Grey List or Selected List Scheme (SLS):
- GPs and other prescribers working in primary care should no longer
prescribe antiviral medicines (including neuraminidase inhibitors) for the
prophylaxis and treatment of influenza on an FP10 prescription form.
- Community pharmacists should no longer supply antiviral medicines in
primary care on presentation of an FP10 prescription form.
This advice stands until a notification is issued to re-commence prescribing and supply of
antiviral medicines in primary care. This does not impact on prescribing of
antiviral medicines in hospitals, which can continue as normal.
Further information, including the
arrangements for prescribing antiviral medicines for localised community
outbreaks, is provided in the attached document from the Chief Medical Officer and Chief Pharmaceutical Officer.